Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
in vitro gene mutation study in bacteria
Type of information:
experimental study
Adequacy of study:
key study
Study period:
08 Mar - 04 Apr 2017
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2017
Report date:
2017

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 471 (Bacterial Reverse Mutation Assay)
Version / remarks:
adopted Jul 1997
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Remarks:
The Department of Health of the Government of the United Kingdom
Type of assay:
bacterial reverse mutation assay

Test material

Constituent 1
Reference substance name:
Fatty acids, C16-18 and C18-hydroxy, oligomeric reaction products with adipic acid, decanoic acid, isooctadecanoic acid, octanoic acid, pentaerythritol and stearic acid
EC Number:
500-320-5
EC Name:
Fatty acids, C16-18 and C18-hydroxy, oligomeric reaction products with adipic acid, decanoic acid, isooctadecanoic acid, octanoic acid, pentaerythritol and stearic acid
Cas Number:
130353-58-1
Molecular formula:
not applicable, the substance is UVCB
IUPAC Name:
1,6-bis({2-[(hexadecanoyloxy)methyl]-3-hydroxy-2-(hydroxymethyl)propyl}) hexanedioate; 1-{2-[(decanoyloxy)methyl]-3-hydroxy-2-[(octadecanoyloxy)methyl]propyl} 6-[3-hydroxy-2-(hydroxymethyl)-2-{[(3-methylheptadecanoyl)oxy]methyl}propyl] hexanedioate; 3-hydroxy-2-{[(6-{[3-hydroxy-2-(hydroxymethyl)-2-[(octadecanoyloxy)methyl]propyl]peroxy}-6-oxohexanoyl)oxy]methyl}-2-(hydroxymethyl)propyl 12-hydroxyoctadecanoate

Method

Target gene:
his operon (S. typhimurium)
trp operon (E. coli)
Species / strain
Species / strain / cell type:
S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and E. coli WP2
Metabolic activation:
with and without
Metabolic activation system:
cofactor supplemented post-mitochondrial fraction (S9 mix), prepared from the livers of rats treated with phenobarbital and β-naphthoflavone.
Test concentrations with justification for top dose:
First experiment: 1.5, 5, 15, 50, 150, 500, 1500 and 5000 µg/plate with and without metabolic activation
Second experiment: 15, 50, 150, 500, 1500 and 5000 µg/plate with and without metabolic activation
Vehicle / solvent:
- Vehicle(s)/solvent(s) used: Tetrahydrofuran
- Justification for choice of solvent/vehicle: In solubility checks performed in–house, the test item was noted as insoluble in sterile distilled water and dimethyl sulphoxide. The test item was noted as initially soluble in dimethyl formamide (50 mg/mL) and acetone (100 mg/mL), however these formulations came out of solution shortly after removal from sonication/heating and could not be considered. The test item was fully soluble in tetrahydrofuran at 200 mg/mL (this formulation stayed in solution), therefore, this solvent was selected as the vehicle.
Controls
Untreated negative controls:
yes
Negative solvent / vehicle controls:
yes
True negative controls:
no
Positive controls:
yes
Positive control substance:
4-nitroquinoline-N-oxide
9-aminoacridine
N-ethyl-N-nitro-N-nitrosoguanidine
benzo(a)pyrene
other: 2-aminoanthracene (1, 2 and 10 µg/plate for TA100, TA1535 and TA1537, and WP2uvrA, respectively, + S9)
Details on test system and experimental conditions:
METHOD OF APPLICATION: in agar (plate incorporation); preincubation

DURATION
- Preincubation period: 20 min (preincubation)
- Exposure duration: Approximately 48 h (plate incorporation and preincubation)

NUMBER OF REPLICATIONS: Triplicates each in 2 independent experiments

DETERMINATION OF CYTOTOXICITY
- Method: Reduction in the growth of the bacterial background lawn
The plates were viewed microscopically for evidence of thinning (toxicity). Manual counts were performed at 5000 μg/plate because of test item precipitation. A number of further manual counts were also performed, predominantly due to colonies spreading and bubble interference, thus distorting the actual plate count. Occasional plates were also manually assessed for accuracy (verification) against the automated counts.
Evaluation criteria:
There are several criteria for determining a positive result. Any, one, or all of the following can be used to determine the overall result of the study:
1. A dose-related increase in mutant frequency over the dose range tested.
2. A reproducible increase at one or more concentrations.
3. Biological relevance against in-house historical control ranges.
4. Statistical analysis of data as determined by UKEMS.
5. Fold increase greater than two times the concurrent solvent control for any tester strain (especially if accompanied by an out-of-historical range response (Cariello and Piegorsch, 1996)).

A test item will be considered non-mutagenic (negative) in the test system if the above criteria are not met.
Although most experiments will give clear positive or negative results, in some instances the data generated will prohibit making a definite judgment about test item activity. Results of this type will be reported as equivocal.
Statistics:
Statistical significance was confirmed by using Dunnetts Regression Analysis (* = p < 0.05) for those values that indicate statistically significant increases in the frequency of revertant colonies compared to the concurrent solvent control

Results and discussion

Test resultsopen allclose all
Key result
Species / strain:
S. typhimurium TA 1535
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity, but tested up to precipitating concentrations
Remarks:
Experiment I: starting at 1500 µg/mL; Experiment II: at 5000 µg/plate
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
Positive controls validity:
valid
Key result
Species / strain:
S. typhimurium TA 1537
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity, but tested up to precipitating concentrations
Remarks:
Experiment I: starting at 1500 µg/mL; Experiment II: at 5000 µg/plate
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
Positive controls validity:
valid
Key result
Species / strain:
S. typhimurium TA 98
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity, but tested up to precipitating concentrations
Remarks:
Experiment I: starting at 1500 µg/mL; Experiment II: at 5000 µg/plate
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
Positive controls validity:
valid
Key result
Species / strain:
S. typhimurium TA 100
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity, but tested up to precipitating concentrations
Remarks:
Experiment I: starting at 1500 µg/mL; Experiment II: at 5000 µg/plate
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
Positive controls validity:
valid
Key result
Species / strain:
E. coli WP2 uvr A
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity, but tested up to precipitating concentrations
Remarks:
Experiment I: starting at 1500 µg/mL; Experiment II: at 5000 µg/plate
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
Positive controls validity:
valid
Additional information on results:
TEST-SPECIFIC CONFOUNDING FACTORS
- Precipitation: Precipitation was observed at concentrations ≥ 1500 µg/plate in Experiment I (plate incorporation) and at 5000 µg/plate in Experiment II (pre-incubation).

HISTORICAL CONTROL DATA (with ranges, means and standard deviation and confidence interval (e.g. 95%)
- Positive historical control data: The positive control data were within the range of the historical control data.
- Negative (solvent/vehicle) historical control data: The solvent and untreated control data were within the range of the historical control data.

Any other information on results incl. tables

Table 1: Results of Experiment I (plate incorporation)

With or without S9-Mix Test substance concentration (μg/plate) Mean number of revertant colonies per plate 
(average of 3 plates ± Standard deviation)
Base-pair substitution type Frameshift type
TA 100 TA1535 WP2uvrA TA98 TA1537
Untreated 112 14 28 20 17
Solvent 126 ± 13 15 ± 2.5 39 ± 12 22 ± 6.1 12 ± 3.5
1.5 122 ± 19.1 16 ± 2.0 43 ± 8.4 37 ± 6.6 ** 15 ± 7.8
5 120 ± 10.6 16 ± 5.7 37 ± 18.5 32 ± 2.5 * 17 ± 5.0
15 127 ± 6.7 16 ± 4.5 42 ± 3.5 34 ± 3.8 ** 16 ± 1.5
50 117 ± 2.8 17 ± 5.0 40 ± 7.4 36 ± 4.2 ** 19 ± 6.0
150 117 ± 12.3 14 ± 4.7 31 ± 18.6 42 ± 2.0 *** 22 ± 3.5 *
500 117 ± 14.6 15 ± 3.1 39 ± 10.7 33 ± 5.2 * 24 ± 4.6 *
1500 P 103 ± 15.6 13 ± 4.9 45 ± 3.6 39 ± 1.0 *** 20 ± 3.1
5000 P 123 ± 13.1 10 ± 4.0 41 ± 5.5 31 ± 5.5 * 16 ± 6.9
Positive controls, –S9 Name  ENNG ENNG ENNG 4NQO 9AA
Concentrations (μg/plate) 3 5 2 0,2 80
Mean No. of colonies/plate (average of 3 ± SD) 440 ± 4.4 480 ± 53.5 844 ± 20.6 196 ± 15.5 405 ± 65.6
+ Solvent 98 ± 6.0 11 ± 1.5 37 ± 6.4 34 ± 6.0 17 ± 2.1
+ 1.5 111 ± 5.3 15 ± 1.5 37 ± 12.2 25 ± 2.3 17 ± 2.3
+ 5 110 ± 4.7 15 ± 2.6 39 ± 7.5 26 ± 14.2 13 ± 3.1
+ 15 107 ± 15.5 13 ± 3.8 40 ± 3.1 29 ± 4.6 12 ± 2.5
+ 50 105 ± 11.7 18 ± 1.7 ** 38 ± 2.1 29 ± 6.5 17 ± 1.0
+ 150 97 ± 9.3 13 ± 4.0 34 ± 3.8 26 ± 3.5 11 ± 4.4
+ 500 104 ± 2.6 11 ± 0.6 40 ± 2.5 26 ± 5.1 13 ± 2.6
+ 1500 P 100 ± 6.81 10 ± 0.0 32 ± 6.1 26 ± 4.0 22 ± 3.5
+ 5000 P 104 ± 2.5 10 ± 2.1 33 ± 9.8 23 ± 4.4 13 ± 1.0
Positive controls, +S9 Name  2AA 2AA 2AA BP 2AA
Concentrations (μg/plate) 1 2 10 5 2
Mean No. of colonies/plate (average of 3 ± SD) 700 ± 54.6 253 ± 16.5 337 ± 16.5 273 ± 25.1 278 ± 11.5

ENNG = N-ethyl-N-nitro-N-nitrosoguanidine

4NQO = 4-nitroquinoline-N-oxide

9AA = 9-aminoacridine

2AA = 2-Aminoanthracene

BP = Benzo(a)pyrene

P = Precipitate

*p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001

Table 2: Comfirmatory Experiment: Without metabolic activation (plate incorporation)

With or without S9-Mix Test substance concentration (μg/plate) Mean number of revertant colonies per plate 
(average of 3 plates ± Standard deviation)
Frameshift type
TA98 TA1537
Untreated 18 16
Solvent 32 ± 11.0 10 ± 3.0
1.5 28 ± 4.0 7 ± 0.6
5 33 ± 2.3 10 ± 3.8
15 33 ± 4.7 12 ± 6.7
50 34 ± 1.2 9 ± 2.1
150 32 ± 2.0 13 ± 1.5
500 33 ± 3.5 12 ± 6.6
1500 P 35 ± 3.8 12 ± 1.7
5000 P 35 ± 5.3 10 ± 1.0
Positive controls, –S9 Name  4NQO 9AA
Concentrations (μg/plate) 0,2 80
Mean No. of colonies/plate (average of 3 ± SD) 209 ± 17.6 280 ± 30.4

4NQO = 4-nitroquinoline-N-oxide

9AA = 9-aminoacridine

P = Precipitate

Table 3: Results of Experiment II (pre-incubation)

With or without S9-Mix Test substance concentration (μg/plate) Mean number of revertant colonies per plate 
(average of 3 plates ± Standard deviation)
Base-pair substitution type Frameshift type
TA 100 TA1535 WP2uvrA TA98 TA1537
Untreated 116 14 32 24 12
Solvent 85 ± 11.0 19 ± 8.1 34 ± 2.9 20 ± 3.1 10 ± 5.6
15 93 ± 4.0 21 ± 1.5 36 ± 4.6 20 ± 10.4 8 ± 1.2
50 90 ± 0.6 19 ± 6.2 24 ± 2.6 21 ± 0.6 9 ± 2.6
150 86 ± 7.9 17 ± 4.4 34 ± 6.0 17 ± 1.5 10 ± 5.2
500 94 ± 3.2 17 ± 2.6 35 ± 6.6 17 ± 8.3 10 ± 1.5
1500 94 ± 4.7 12 ± 0.6 29 ± 3.6 19 ± 4.2 8 ± 1.5
5000 P 100 ± 3.0 * 13 ± 1.5 36 ± 1.2 22 ± 3.8 12 ± 0.6
Positive controls, –S9 Name  ENNG ENNG ENNG 4NQO 9AA
Concentrations (μg/plate) 3 5 2 0,2 80
Mean No. of colonies/plate (average of 3 ± SD) 773 ± 103.9 572 ± 26.7 520 ± 72.1 240 ± 43.8 160 ± 2.9
+ Solvent 99 ± 11.7 10 ± 1.0 41 ± 4.0 25 ± 4.0 10 ± 4.0
+ 15 107 ± 13.1 10 ± 2.5 48 ± 1.7 17 ± 4.0 8 ± 2.6
+ 50 93 ± 1.2 13 ± 4.0 41 ± 5.1 24 ± 6.0 13 ± 5.5
+ 150 95 ± 10.2 9 ± 0.6 35 ± 6.0 25 ± 7.5 10 ± 2.5
+ 500 105 ± 6.5 8 ± 1.7 37 ± 15.6 17 ± 3.6 11 ± 5.0
+ 1500 103 ± 11.1 15 ± 2.1 * 43 ± 3.2 26 ± 1.0 14 ± 5.1
+ 5000 P 94 ± 11.5 8 ± 1.0 41 ± 7.5 24 ± 3.2 10 ± 2.5
Positive controls, +S9 Name  2AA 2AA 2AA BP 2AA
Concentrations (μg/plate) 1 2 10 5 2
Mean No. of colonies/plate (average of 3 ± SD) 980 ± 129 203 ± 15.6 234 ± 29.1 93 ± 22.5 180 ± 18.6

ENNG = N-ethyl-N-nitro-N-nitrosoguanidine

4NQO = 4-nitroquinoline-N-oxide

9AA = 9-aminoacridine

2AA = 2-Aminoanthracene

BP = Benzo(a)pyrene

P = Precipitate

*p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001

Table 4: Historical control data

Combined vehicle and untreated control values: 2015                    
Strain S9-Mix TA100 TA1535 WP2uvrA    TA98    TA1537
  -S9 +S9 -S9 +S9 -S9 +S9 -S9 +S9 -S9 +S9
Values † 274 278 504 285 461 229 526 299 506 282
Min 60 61 7 7 10 12 11 10 4 6
Max 166 175 31 29 58 43 45 46 27 27
Mean 91 95 16 14 24 27 21 24 12 13
SD 19.3 19.1 4.5 4.0 5.6 5.9 6.2 6.1 3.8 3.4
Positive control values 2015                    
Strain S9-Mix TA100 TA1535 WP2uvrA    TA98    TA1537
  -S9 +S9 -S9 +S9 -S9 +S9 -S9 +S9 -S9 +S9
Values 276 280 252 264 231 227 262 276 253 261
Min 222 250 79 118 116 103 100 78 164 97
Max 2266 2402 2779 457 2769 550 502 705 2318 823
Mean 614 927 472 246 792 266 222 218 911 336
SD 260.6 452.5 434.8 55.7 342.1 97.7 70.2 107.6 412.4 135.7
Combined vehicle and untreated control values: 2016                    
Strain S9-Mix TA100 TA1535 WP2uvrA    TA98    TA1537
  -S9 +S9 -S9 +S9 -S9 +S9 -S9 +S9 -S9 +S9
Values 399 401 758 393 690 345 788 415 762 398
Min 63 66 8 8 10 13 8 12 3 4
Max 154 156 34 39 53 53 49 51 24 23
Mean 90 93 15 15 22 27 21 25 12 13
SD 14.5 14.3 4.5 5.2 5.8 6.3 4.8 5.7 3.5 3.5
Positive control values 2016                    
Strain S9-Mix TA100 TA1535 WP2uvrA    TA98    TA1537
  -S9 +S9 -S9 +S9 -S9 +S9 -S9 +S9 -S9 +S9
Values 409 406 381 386 341 335 388 385 379 381
Min 221 284 84 92 107 102 100 96 95 101
Max 2222 2863 2994 879 1611 637 449 4357 1413 639
Mean 724 1264 854 240 718 240 186 188 406 290
SD 320.4 562.9 664.9 62.1 338.6 98.2 49.8 230.8 227.0 92.7

Applicant's summary and conclusion

Conclusions:
Interpretation of results: negative